Safe and effective profile of the VSTENT bioresorbable polymer sirolimus-eluting stent in the treatment of patients with coronary artery lesions: a prospective, cohort, multicenter study.

Background: The drug-eluting stent was a significant stride forward in the development of enhanced therapeutic therapy for coronary intervention, with three generations of increased advancement. VSTENT is a newly developed stent manufactured in Vietnam that aims to provide coronary artery patients with a safe, effective, and cost-efficient option. The purpose of this trial was to determine the efficacy and safety of a new bioresorbable polymer sirolimus-eluting stent called VSTENT.